Neuren Pharmaceuticals LimitedASX: NEU

Ethics approval for Angelman Phase 2 trial in Australia

Mar 11, 2022 at 3:54 AM UTC · Issued by Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Ltd has released a press release.

View Attachment